Tweet
Balter Liquid Alternatives LLC grew its stake in Invacare Co. (NYSE:IVC) by 37.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 72,177 shares of the health services provider's stock after acquiring an additional 19,757 shares during the quarter. Invacare comprises about 1.1% of Balter Liquid Alternatives LLC's portfolio, making the stock its 16th biggest position. Balter Liquid Alternatives LLC owned approximately 0.22% of Invacare worth $1,346,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also made changes to their positions in the stock. BlackRock Inc. grew its stake in Invacare by 3.2% during the 1st quarter. BlackRock Inc. now owns 4,609,315 shares of the health services provider's stock worth $80,203,000 after buying an additional 143,659 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Invacare by 3.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,770,365 shares of the health services provider's stock worth $48,204,000 after buying an additional 88,888 shares during the last quarter. Millennium Management LLC grew its stake in Invacare by 318.5% during the 1st quarter. Millennium Management LLC now owns 1,455,746 shares of the health services provider's stock worth $25,330,000 after buying an additional 1,107,858 shares during the last quarter. Elk Creek Partners LLC grew its stake in Invacare by 53.0% during the 1st quarter. Elk Creek Partners LLC now owns 1,388,380 shares of the health services provider's stock worth $24,158,000 after buying an additional 480,755 shares during the last quarter. Finally, Royal Bank of Canada grew its stake in Invacare by 32.5% during the 1st quarter. Royal Bank of Canada now owns 1,155,919 shares of the health services provider's stock worth $20,113,000 after buying an additional 283,846 shares during the last quarter. Get Invacare alerts:
Invacare stock opened at $15.85 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.41 and a debt-to-equity ratio of 0.64. The stock has a market cap of $555.38 million, a price-to-earnings ratio of -8.21 and a beta of 2.38. Invacare Co. has a fifty-two week low of $13.13 and a fifty-two week high of $20.00. Invacare (NYSE:IVC) last posted its quarterly earnings results on Tuesday, August 7th. The health services provider reported ($0.41) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.30) by ($0.11). The firm had revenue of $246.15 million for the quarter, compared to analysts' expectations of $247.90 million. Invacare had a negative net margin of 6.80% and a negative return on equity of 12.52%. research analysts forecast that Invacare Co. will post -1.02 earnings per share for the current year.
Several brokerages recently weighed in on IVC. KeyCorp dropped their target price on Invacare from $24.00 to $23.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 9th. Zacks Investment Research downgraded Invacare from a "buy" rating to a "hold" rating in a research note on Wednesday, July 11th. UBS Group upgraded Invacare from a "sell" rating to a "neutral" rating in a research note on Wednesday, May 2nd. ValuEngine upgraded Invacare from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 8th. Finally, TheStreet downgraded Invacare from a "c" rating to a "d+" rating in a research note on Friday, August 10th. Two investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. The stock has a consensus rating of "Buy" and an average target price of $21.50.
In other Invacare news, SVP Dean J. Childers sold 7,000 shares of the business's stock in a transaction dated Friday, June 29th. The stock was sold at an average price of $18.71, for a total transaction of $130,970.00. Following the sale, the senior vice president now owns 34,631 shares in the company, valued at approximately $647,946.01. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website . Also, Director C Martin Harris sold 2,582 shares of the business's stock in a transaction dated Wednesday, May 23rd. The shares were sold at an average price of $16.38, for a total value of $42,293.16. The disclosure for this sale can be found here . In the last quarter, insiders have sold 33,582 shares of company stock worth $643,663. Company insiders own 2.10% of the company's stock.
Invacare Company Profile
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific.
Recommended Story: What do investors mean by earnings per share?
Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Co. (NYSE:IVC). Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter 